Lower Dose Infliximab for Ulcerative Colitis: How Low Can We Go and How Much Can be Saved?
- George P. Christophi
- , Matthew A. Ciorba
- Division of Gastroenterology
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Bursky Center for Human Immunology and Immunotherapy
- Center of Regenerative Medicine
- DBBS - Immunology
- DBBS - Molecular Microbiology and Microbial Pathogenesis
- DBBS - Cancer Biology
Research output: Contribution to journal › Editorial
1
Link opens in a new tab
Scopus
citations